D-0975-2015 Class II Terminated

Recalled by Wockhardt Usa Inc. — Parsippany, NJ

FDA drug recall D-0975-2015 was initiated by Wockhardt Usa Inc. on Mar 12, 2015 and is designated Class II. Reason for recall: Failed Tablet/Capsule Specifications: out of specification for thickness. The recall status is terminated (terminated Dec 14, 2017). Affected quantity: 93,393 bottles.

Recall details

Product Type
Drugs
Report Date
May 13, 2015
Initiation Date
Mar 12, 2015
Termination Date
Dec 14, 2017
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
93,393 bottles

Product description

Captopril Tablets, USP 12.5 mg, Rx Only, a) 100 count bottles NDC 64679-902-01, b) 1000 count bottles NDC 64679-902-02, Manufactured by Wockhardt Limited, Mumbai, India, Distributed by: Wockhardt USA LLC., 20 Waterview Boulevard, Parsippany, NJ 07054 USA

Reason for recall

Failed Tablet/Capsule Specifications: out of specification for thickness.

Distribution pattern

Nationwide

Code information

Lot #s: a) LM10525, Exp 03/15; LM10727, Exp 04/15; LM11519, Exp 08/15; LN10008, Exp 11/15; LN10121, Exp 12/15; LN10887, Exp 04/16; LM11248, Exp 06/16 Lot #s: b) LM10522, Exp 03/15; LM10726, Exp 04/15; LN10007, Exp 11/15; LN10116, Exp 12/15; LN10888, Exp 04/16; LN11281 Exp 07/16

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0975-2015
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0975-2015. Report a data issue: hello@regdatalab.com.